Biological and Clinical Markers in Panic Disorder

키워드

참고문헌 (104)

1. EKalia M, "Biomarkers of psychiatric diseases : current status and future prospects", Metabolism, 64, pp.S11~S15 (2015)
2. Scarr E, "Biomarkers for psychiatry : the journey from fantasy to fact, a report of the 2013 CINP think tank", Int J Neuropsychopharmacol, 18, pp.1~9 (2015)
3. "Biomarkers Definitions Working Group Biomarkers and surrogate endpoints", Clin Pharmacol Ther, 69, pp.89~95 (2001)
4. Venkatasubramanian G, "Biomarkers in psychiatry-a critique", Ann Neurosci, 23, pp.3~5 (2016)
5. Macaluso M, "How biomarkers will change psychiatry: from clinical trials to practice. Part I, Introduction", J Psychiatr Pract, 18, pp.118~121 (2012)
6. Amur S, "Biomarker qualification : toward a multiple stakeholder framework for biomarker development, regulatory acceptance, and utilization", Clin Pharacol Ther, 98, pp.34~46 (2015)
7. Ankeny JS, "Review of diagnostic, prognostic, and predictive biomarkers in melanoma", Clin Exp Metastasis, 35, pp.487~493 (2018)
8. FDA-NIH Biomarker Working Group, "BEST (Biomarkers, Endpoints, and Other Tools) Resource", Food and Drug Administration (US), National Institutes of Health(US), ~ (2016)
9. Bandelow B, "Biological markers for anxiety disorders, OCD and PTSD–a consensus statement. Part I: neuroimaging and genetics", World J Biol Psychiatry, 17, pp.321~365 (2016)
10. Bandelow B, "Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition", World J Biol Psychiatry, 18, pp.162~214 (2017)
11. Hayano F, "Smaller amygdala is associated with anxiety in patients with panic disorder", Psychiatry Clin Neurosci, 63, pp.266~276 (2009)
12. De Cristofaro MT, "Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients : a SPECT study", Biol Psychiatry, 33, pp.505~512 (1993)
13. Gecici O, "Evaluation of cerebral blood flow volume using color duplex sonography in patients with untreated panic disorder", Psychiatry Clin Neurosci, 59, pp.676~682 (2005)
14. Gorman JM, "A neuroanatomical hypothesis for panic disorder", Am J Psychiatry, 146, pp.148~161 (1989)
15. Perna G, "Panic disorder : from respiration to the homeostatic brain", Acta Neuropsychiatr, 16, pp.57~67 (2004)
16. Grassi M, "Baseline re-spiratory parameters in panic disorder a meta-analysis", J Affect Disord, 146, pp.158~173 (2013)
17. Grassi M, "Are respiratory abnormalities specific for panic disorder? A meta-analysis", Neuropsychobiology, 70, pp.52~60 (2014)
18. Roth WT, "Physiological markers for anxiety : panic disorder and phobias", Int J Psychophysiol, 58, pp.190~198 (2005)
19. Niccolai V, "Respiratory patterns in panic disorder reviewed : a focus on biological challenge tests", Acta Psychiatr Scand, 120, pp.167~177 (2009)
20. Chalmers JA, "Anxiety disorders are associated with reduced heart rate variability: a meta-analysis", Front Psychiatry, pp.5~80 (2014)
21. Hillebrand S, "Heart rate variability and first cardiovascular event in populations without known cardiovascular disease : meta-analysis and dose–response meta-regression", Europace, 15, pp.742~749 (2013)
22. Davies SJ, "Association of panic disorder and panic attacks with hypertension", Am J Med, 107, pp.310~316 (1999)
23. Davies SJ, "A U-shaped relationship between systolic blood pressure and panic symptoms : the HUNT study", Psychol Med, 42, pp.1969~1976 (2012)
24. Gorman JM, "Heart rate variability in depressive and anxiety disorders", Am Heart J, 140, pp.S77~S83 (2000)
25. Bhad R, "Red blood cell and platelet indices : a potential biomarker for panic disorder", J Neurosci Rural Pract, 8, pp.164~ (2017)
26. Ransing RS, "Mean platelet volume and platelet distribution width level in patients with panic disorder", J Neurosci Rural Pract, 8, pp.174~178 (2017)
27. Asoglu M, "Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder", Neuropsychiatr Dis Treat, 12, pp.2435~2438 (2016)
28. Ising M, "Stress response regulation in panic disorder", Curr Pharm Des, 18, pp.5675~5684 (2012)
29. Heim C, "Neurobiological and psychiatric consequences of child abuse and neglect", Dev Psychobiol, 52, pp.671~690 (2010)
30. Danese A, "Adverse childhood experiences, allostasis, allostatic load, and age-related disease", Physiol Behav, 106, pp.29~39 (2012)
31. Du X, "Is dysregulation of the HPA-axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases?", Front Psychiatry, 6, pp.32~ (2015)
32. Faravelli C, "The role of life events and HPA axis in anxiety disorders : a review", Curr Pharm Des, 18, pp.5663~5674 (2012)
33. Bandelow B, "Salivary cortisol in panic attacks", Am J Psychiatry, 157, pp.454~456 (2000)
34. Jakuszkowiak-Wojten K, "Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review", Psychiatr Danub, 27(Suppl 1), pp.S445~S451 (2015)
35. Bandelow B, "Panic Disorder and Agoraphobia" (2013), Oxford Psychiatry Library
36. Graeff FG, "Anxiety, panic and the hypothalamic-pituitary-adrenal axis", Revista Brasileira de Psiquiatria, 29, pp.s3~s6 (2007)
37. Graeff FG, "The hypothalamic-pituitary-adrenal axis in anxiety and panic", Psychol Neurosci, 3, pp.3~8 (2010)
38. Schommer NC, "Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress", Psychosom Med, 65, pp.450~460 (2003)
39. Abelson JL, "Hypothalamic-pituitary-adrenal axis activity in panic disorder : prediction of long-term outcome by pretreatment cortisol levels", Am J Psychiatry, 153, pp.69~73 (1996)
40. Coryell W, "The prognostic significance of HPA-axis disturbance in panic disorder : a three-year follow-up", Biol Psychiatry, 29, pp.96~102 (1991)
41. Machado S, "Panic disorder and cardiovascular diseases : an overview", Int Rev Psychiatry, 29, pp.436~444 (2017)
42. Grambal A, "Predictors of poor treatment response to additional CBT in real panic disorder patients : the role of DLPF, orbitofrontal cortex, parietal lobule, frontal eye field and amygdala in PD", Neuro Endocrinol Lett, 36, pp.269~281 (2015)
43. Fischer S, "Cortisol as a predictor of psychological therapy response in anxiety disorders-systematic review and meta-analysis", J Anxiety Disord, 47, pp.60~68 (2017)
44. Cloninger CR, "Psychiatric Diagnosis and Classification", pp.79~105 (2002), Wiley
45. Boksa P, "A way forward for research on biomarkers for psychiatric disorders", J Psychiatry Neurosci JPN, 38, pp.75~77 (2013)
46. Bassett D, "A literature review of heart rate variability in depressive and bipolar disorders", Aust N Z J Psychiatry, 50, pp.511~519 (2016)
47. Bradley AJ, "A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality", J Psychopharmacol, 24(4 Suppl), pp.91~118 (2010)
48. Brunoni AR, "Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study", Int J Neuropsychopharmacol, 16, pp.1937~1949 (2013)
49. Delgado PL, "Role of norepinephrine in depression", J Clin Psychiatry, 61(Suppl 1), pp.5~12 (2000)
50. Faravelli C, "Childhood adversity, cortisol levels, and psychosis : a retrospective investigation", J Nerv Ment, 205, pp.574~579 (2017)
51. Gundogmus İ, "PDW and RDW are new parameters for bipolar episodes and unipolar depression", Psychiatry Clin Psychopharmacol, pp.1~7 (2018)
52. Belvederi Murri M, "The HPA axis in bipolar disorder : systematic review and meta-analysis", Psychoneuroendocrinology, 63, pp.327~342 (2016)
53. Rajarethinam R, "Hippocampus and amygdala in schizophrenia : assessment of the relationship of neuroanatomy to psychopathology", Psychiatry Res, 108, pp.79~87 (2001)
54. Ressler KJ, "Role of norepinephrine in the pathophysiology and treatment of mood disorders", Biol Psychiatry, 46, pp.1219~1233 (1999)
55. Goodkind M, "Identification of a common neurobiological substrate for mental illness", JAMA Psychiatry, 72, pp.305~315 (2015)
56. Valkonen‐Korhonen M, "Heart rate variability in acute psychosis", Psychophysiology, 40, pp.716~726 (2003)
57. Young AH, "Cortisol in mood disorders", Stress, 7, pp.205~208 (2004)
58. Kim JH, "Relationship between heart rate variability and the severity of psychotic symptoms in schizophrenia", Acta Neuropsychiatr, 23, pp.161~166 (2011)
59. Fava GA, "The missing link between clinical states and biomarkers in mental disorders", Psychother Psychosom, 83, pp.136~141 (2014)
60. Kapur S, "Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?", Mol Psychiatry, 17, pp.1174~1179 (2012)
61. Fava GA, "Behavioral toxicity revisited : iatrogenic comorbidity in psychiatric evaluation and treatment", J Clin Psychopharmacol, 36, pp.550~553 (2016)
62. Tomba E, "What psychologists need to know about psychotropic medications", Clin Psychol Psychother, 25, pp.181~187 (2018)
63. Feinstein AR, "Basic biomedical science and the destruction of the pathophysiological bridge from bench to bedside", Am J Med, 107, pp.461~467 (1999)
64. Fava GA, "The clinical process in psychiatry : a clinimetric approach", J Clin Psychiatry, 73, pp.177~184 (2012)
65. Wright JG, "A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales", J Clin Epidemiol, 45, pp.1201~1218 (1992)
66. Fava GA, "Psychometric theory is an obstacle to the progress of clinical research", Psychother Psychosom, 73, pp.145~148 (2004)
67. Tomba E, "Clinimetrics and clinical psychometrics : macro-and micro-analysis", Psychother Psychosom, 81, pp.333~343 (2012)
68. Feinstein AR, "T. Duckett Jones Memorial Lecture. The Jones criteria and the challenge of clinimetrics", Circulation, 66, pp.1~5 (1982)
69. Cosci F, "The family assessment device : a clinimetric analysis", Psychother Psychosom, 85, pp.241~243 (2016)
70. Timmerby N, "A systematic review of the clinimetric properties of the 6-item version of the Hamilton Depression Rating Scale (HAM-D6)", Psychother Psychosom, 86, pp.141~149 (2017)
71. Timmerby N, "A confirmative clinimetric analysis of the 36-item Family Assessment Device", Nord J Psychiatry, 72, pp.268~272 (2018)
72. American Psychiatric Association, "Diagnostic and statistical Manual of Mental Disorders" (1980), American Psychiatric Association
73. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (1987), American Psychiatric Association
74. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders(DSM-IV)" (1994), American Psychiatric Association
75. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (2000), American Psychiatric Association
76. American Psychiatric Association, "Diagnostic and Satistical Mnual of Mntal Dsorders" (2013), American Psychiatric Association
77. World Health Organization, "Manual of the 28. International Statistical Classification of Diseases, Injuries, and Causes of Death. Sixth Revision of the International Lists of Diseases and Causes of Death. Adopted 1948", World Health Organization, ~ (1948)
78. World Health Organization, "Manual of the 30. International Statistical Classification of Diseases, Injuries, and Causes of Death. Based on the Recommendations of the Seventh Revision Conference, 1955, and Adopted by the Ninth World Health Assembly under the WHO Nomenclature Regulations", World Health Organization, ~ (1957)
79. World Health Organization, "Manual of the 32. International Statistical Classification of Diseases, Injuries, and Causes of Death. Based on Recommendations of the Eighth Revision Conference, 1965, and Adopted by the Nineteenth World Health Assembly", World Health Organization, ~ (1967)
80. World Health Organization, "Manual of the 34. International Classification of Diseases, Injuries, and Causes of Death, Based on the Recommendations of the Ninth Revision Conference, 1975, and Adopted by the Twenty-Ninth World Health Assembly", World Health Organization, ~ (1977)
81. Fava GA, "New modalities of assessment and treatment planning in depression : the sequential approach", CNS Drugs, 24, pp.453~465 (2010)
82. Bech P, "Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton", Psychother Psychosom, 78, pp.202~211 (2009)
83. Faravelli C, "Assessment of psychopathology", Psychother Psychosom, 73, pp.139~141 (2004)
84. First MB, "Do mental health professionals use diagnostic classifications the way we think they do? A global survey", World Psychiatry, 17, pp.187~195 (2018)
85. Maj M, "Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them", World Psychiatry, 17, pp.121~122 (2018)
86. Cosci F, "Staging of mental disorders : systematic review", Psychother Psychosom, 82, pp.20~34 (2013)
87. Feinstein AR, "Clinimetrics" (1987), Yale University Press
88. Feinstein AR, "An analysis of diagnostic reasoning: I. The domains and disorders of clinical macrobiology", Yale J Biol Med, 46, pp.212~232 (1973)
89. Fava GA, "Clinical judgment in psychiatry. Requiem or reveille?", Nord J Psychiatry, 67, pp.1~10 (2013)
90. Feinstein AR, "Multi-item ‘instruments’ versus Virginia Apgar’s principles of clinimetrics", Arch Intern Med, 159, pp.125~128 (1999)
91. Taylor GJ, "Affects, trauma, and mechanisms of symptom formation: a tribute to John C. Nemiah, MD (1918-2009)", Psychother Psychosom, 79, pp.339~349 (2010)
92. Faravelli C, "Number of symptoms, quantification, and qualification of depression", Compr Psychiatry, 37, pp.307~315 (1996)
93. McGorry PD, "The next stage for diagnosis : validity through utility", World Psychiatry, 12, pp.213~215 (2013)
94. Fava GA, "Staging : a neglected dimension in psychiatric classification", Acta Psychiatr Scand, 87, pp.225~230 (1993)
95. Cosci F, "The psychological development of panic disorder : implications for neurobiology and treatment", Revista Brasileira de Psiquiatria, 34, pp.9~19 (2012)
96. Sheehan DV, "The classification of anxiety and hysterical states. Part II. Toward a more heuristic classification", J Clin Psychopharmacol, 2, pp.386~393 (1982)
97. Fava GA, "Agoraphobia is a disease : a tribute to Sir Martin Roth", Psychother Psychosom, 77, pp.133~138 (2008)
98. Fava GA, "Subclinical symptoms of panic disorder : new insights into pathophysiology and treatment", Psychother Psychosom, 68, pp.281~289 (1999)
99. Fava GA, "The spectrum of anxiety disorders in the medically ill", J Clin Psychiatry, 71, pp.910~914 (2010)
100. Fava GA, "Current psychosomatic practice", Psychother Psychosom, 86, pp.13~30 (2017)
101. Fava GA, "Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia", J Affect Disord, 65, pp.185~190 (2001)
102. "The role of staging in planning psychotherapeutic interventions in depression", J Clin Pychiatry, 78, pp.456~463 (2017)
103. Porter E, "A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia", Clin Psychol Rev, 42, pp.179~192 (2015)
104. Slaap BR, "The prediction of nonresponse to pharmacotherapy in panic disorder : a review", Depress Anxiety, 14, pp.112~122 (2001)

관련 논문AI추천